Nuveen Asset Management’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-81,898
| Closed | -$332K | – | 3329 |
|
2023
Q4 | $332K | Hold |
81,898
| – | – | ﹤0.01% | 3127 |
|
2023
Q3 | $780K | Sell |
81,898
-580
| -0.7% | -$5.52K | ﹤0.01% | 2678 |
|
2023
Q2 | $770K | Buy |
82,478
+60,629
| +277% | +$566K | ﹤0.01% | 2761 |
|
2023
Q1 | $194K | Hold |
21,849
| – | – | ﹤0.01% | 2991 |
|
2022
Q4 | $109K | Sell |
21,849
-14,787
| -40% | -$73.8K | ﹤0.01% | 3104 |
|
2022
Q3 | $212K | Buy |
36,636
+4,918
| +16% | +$28.5K | ﹤0.01% | 3107 |
|
2022
Q2 | $175K | Buy |
31,718
+14,224
| +81% | +$78.5K | ﹤0.01% | 3158 |
|
2022
Q1 | $202K | Hold |
17,494
| – | – | ﹤0.01% | 3193 |
|
2021
Q4 | $222K | Buy |
+17,494
| New | +$222K | ﹤0.01% | 3225 |
|